Next-Gen Yellow Fever Vaccine Hits the Mark in Mid-Stage Trial

(MedPage Today) — An investigational yellow fever (vYF) vaccine that could help avoid shortages matched the immunogenicity and safety profile of the FDA-approved vaccine (YF-VAX), a Phase II trial found. In healthy adults without a history…